Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Don't Take For Granted A Patient's Role In Clinical Trials, Experts Say

Executive Summary

Catering to patients can help make clinical trials more accessible and useful, presenters argued at a recent conference.

You may also be interested in...



Minute Insight: Amazon Partners With Thread To Help Decentralize Clinical Trials

Thread, a technology and consulting service provider, signed a deal with Amazon Web Services to enable faster, more efficient subject monitoring and data collection in clinical trials.

EMA Consults On Proposed Framework For Patient Preference Studies

The EMA is inviting feedback on its plans to ratify, with some caveats, a new framework on how to use patient preferences as input in medical product decision-making. The framework was developed under the EU’s public-private Innovative Medicines Initiative.

FDA Will Keep Listening To Patient-Engagement Experts

The US agency says in a 6 January Federal Register notice that it’s keeping its Patient Engagement Advisory Committee in place through October 2021 so it can gather more patient feedback that will come in handy when regulatory decisions need to be made. The committee, formed after the agency made a cultural shift to consider patient input on the types of products it allows on the market, was supposed to expire October 2019.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT126312

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel